Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes-Reference-Cited by-同舟云学术

Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes

Published:2006-04-05 Issue:2 Volume:13 Page:133-143
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:

Author:

Birner Peter,Piribauer Maria,Fischer Ingeborg,Gatterbauer Brigitte,Marosi Christine,Ambros Peter F.,Ambros Inge M.,Bredel Markus,Oberhuber Georg,Rössler Karl,Budka Herbert,Harris Adrian L.,Hainfellner Johannes A.

Publisher

Wiley

Subject

Neurology (clinical),Pathology and Forensic Medicine,General Neuroscience

Reference48 articles.

1. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines;Ambros;Med Pediatr Oncol,2001

2. Stabilization of wild-type p53 by hypoxia-inducible factor 1a;An;Nature,1998

3. Aquantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites;Bernsen;Microvasc Res,1999

4. Expression of hypoxia-inducible factor 1a in oligoden-drogliomas: its impact on prognosis and on neoangio-genesis;Birner;Cancer,2001

5. Prognostic relevance of p53 protein expression in glioblastoma;Birner;Oncol Rep,2002

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing glioblastoma treatment by targeting metabolism;Neoplasia;2024-05

2. ABCG2 Expression as a Potential Survival Predictor in Human Gliomas;International Journal of Molecular Sciences;2024-03-08

3. Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications;Oncology Research;2024

4. Computational Fractal-Based Analysis of Brain Tumor Microvascular Networks;Advances in Neurobiology;2024

5. Unlocking Bevacizumab’s Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients;Cancers;2023-12-28